Interview with Amy Kaji & Ryan Pedigo Why did you feel that it was important to write Emergency Medicine Board Review? What does it add to the field?  Dr Kaji: I think a review book is a welcome addition to the library of EM books that combines easy, fast bullet points, combined with questions.   Dr.MORE

Debra L. Beck and Eugene Braunwald, MD  After percutaneous coronary intervention (PCI), guidelines recommend indefinite maintenance therapy with a single antiplatelet agent after the initial 6- to 12-months of dual antiplatelet therapy (DAPT). Aspirin is the most widely used standard antiplatelet agent, with clopidogrel recommended as an alternative strategy. The HOST-EXAM trial was an investigator-initiated, prospective, randomized, open-label, multicenter trial comparing the efficacy and safetyMORE

Why did you feel that it was important to write a book on Spanish clinical cases and exam review? What does your publication add to the field? A growing number of medical schools, universities, and hospitals are looking for ways for their students and clinical staff to better communicate with the growing Spanish-speaking population. While the number of courses that teachMORE

Debra L. Beck and Eugene Braunwald, MD  Semaglutide is a is a glucagon-like peptide-1 (GLP-1) receptor agonist that is approved, at doses up to 1 mg administered subcutaneously once weekly, for the treatment of type 2 diabetes in adults and for reducing the risk of cardiovascular events in persons with type 2 diabetes and cardiovascular disease. In the global phaseMORE